clinical experience of using biological hepatoprotector prohepar in the treatment of patients with hepatobiliary pathology (review)
Abstract
The article provides an overview of researches to assess the efficacy and safety of using biological hepatoprotector Prohepar in patients with chronic diffuse liver diseases. Used regimens contribute to the normalization of liver function tests, improve general condition of the patient, in particular a decrease in the manifestations of asthenic syndrome.
Keywords
Access
Citation
ID:
217869
Ref Key:
stepanov2015gastroenterologaclinical
Use this key to autocite in
SciMatic or
Thesis Manager
References
Blockchain Verification
Account:
NFT Contract Address:
0x95644003c57E6F55A65596E3D9Eac6813e3566dA
Article ID:
217869
Unique Identifier:
10.22141/2308-2097.3.57.2015.81536
Network:
Scimatic Chain (ID: 481)
Loading...
Blockchain Readiness Checklist
Authors
Abstract
Journal Name
Year
Title
Creates 1,000,000 NFT tokens for this article
Token Features:
- ERC-1155 Standard NFT
- 1 Million Supply per Article
- Transferable via MetaMask
- Permanent Blockchain Record
Scan with Saymatik Web3.0 Wallet
